Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,770.56 -64.45 -2.27%
FTSE 100 6,721.10 -119.17 -1.74%
DAX 8,336.49 -194.40 -2.28%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,660.50 -600.59 -2.58%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: Xetra
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Diagnostic Kits

QIA:GR

14.453 EUR 0.227 1.55%

As of 04:00:57 ET on 05/23/2013.

Company Profile for QIAGEN NV (QIA)

QIAGEN N.V. provides sample and assay technologies. The Company's technologies (in the format of consumables and automated solutions) are used to process biological samples and to analyze analytes contained therein, such as DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.

Contact Information

QIAGEN NV

Sportstraat 50
Venlo, 5911 KJ
Netherlands
Phone: 31-77-320-8400
Fax: 31-77-320-8409

Key Executives for QIAGEN NV (QIA)

Peer M SchatzCEO/Managing DirectorRoland SackersCFO/Managing Director
Tadd S LazarusChief Medical OfficerBernd UderSenior VP:Global Sales/Mng Dir
Helge LubenowSenior VP/Head:Bus AreaJohn GilardiVP:Corporate Communications
Peter J VozzoDir:Global Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil